Steroid hormone receptor association with prognostic markers in breast carcinoma in Northern Pakistan
- PMID: 20392381
Steroid hormone receptor association with prognostic markers in breast carcinoma in Northern Pakistan
Abstract
Objective: To determine steroid hormone receptor expression and their association with histological prognostic markers and biological profile in female breast carcinoma in Northern Pakistan.
Study design: Cross sectional, observational.
Place and duration of study: Department of Histopathology, Armed Forces Institute of Pathology, Rawalpindi, from January 2004 to December 2007.
Methodology: Female patients belonging to Northern Pakistan with primary operable breast carcinoma were included in the study. Patient's age, microscopic tumour size, tumour grade, lymph node status and biological profile for Her-2/neu status were evaluated. Immunohistochemical expression for ER and PR was determined individually and conjointly for ER+PR+ and ER-PR- while their association with above prognostic markers was determined using the c2 test for univariate analysis.
Results: Out of the 726 cases, there were 657 (90.4%) cases of infiltrating ductal carcinoma with mean age of 48+/-12 years and mean tumour size of 4.2+/-2.3 cm. Tumour was grade-II in 65% and lymph node metastases in 71.5% cases with Her-2/neu+ in 28.1%. ER and PR expression was 74.6% and 68.3% respectively. Conjoint expression of ER+PR+ was 456 (62.8%), ER-PR- in 21.2%, ER+PR- in 86 (11.8%) and ER-PR+ in 30 (4.1%) cases. Individually, ER and PR showed positive association with age, lymph node metastasis, tumour grade and inverse association with Her-2/neu. Conjoint expression of ER+PR+ (62.8%) and ER-PR-(21.2%) showed positive association with age, tumour grade, lymph node metastasis and inverse association with Her-2/neu (p < 0.05).
Conclusion: Hormone receptor expression of ER and PR expression is comparable to the West with ER and PR showing inverse association with Her-2/neu and positive association with age, tumour grade and lymph node metastases.
Similar articles
-
Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.J Coll Physicians Surg Pak. 2009 Feb;19(2):99-103. J Coll Physicians Surg Pak. 2009. PMID: 19208313
-
Age related association of Her-2/neu with prognostic markers in female breast carcinoma.J Coll Physicians Surg Pak. 2010 Sep;20(9):590-4. J Coll Physicians Surg Pak. 2010. PMID: 20810050
-
Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.J Ayub Med Coll Abbottabad. 2008 Jul-Sep;20(3):23-6. J Ayub Med Coll Abbottabad. 2008. PMID: 19610508
-
Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma.Breast Cancer Res Treat. 2012 Aug;135(1):29-37. doi: 10.1007/s10549-012-2047-z. Epub 2012 Apr 8. Breast Cancer Res Treat. 2012. PMID: 22484731 Review.
-
Hormone receptor expression in breast cancer: postanalytical issues.J Clin Pathol. 2013 Jun;66(6):478-84. doi: 10.1136/jclinpath-2012-201148. Epub 2013 Mar 22. J Clin Pathol. 2013. PMID: 23526546 Review.
Cited by
-
OGG1 Mutations and Risk of Female Breast Cancer: Meta-Analysis and Experimental Data.Dis Markers. 2015;2015:690878. doi: 10.1155/2015/690878. Epub 2015 May 19. Dis Markers. 2015. PMID: 26089588 Free PMC article.
-
Expression of the Androgen Receptor, pAkt, and pPTEN in Breast Cancer and Their Potential in Prognostication.Transl Oncol. 2014 May 12;7(3):355-62. doi: 10.1016/j.tranon.2014.04.004. Online ahead of print. Transl Oncol. 2014. PMID: 24831579 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous